Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CNB Financial Corp
CCNE
$749M
| $947K | ﹤0.01% |
52,301
-1,300
| -2% | -$23.5K |
|
2352
Black Diamond Therapeutics
BDTX
$180M
| $944K | ﹤0.01% |
328,900
+108,200
| +49% | +$311K |
|
2353
ProShares Short High Yield
SJB
$68.4M
| $943K | ﹤0.01% |
51,100
-4,100
| -7% | -$75.7K |
|
|
AHT
2354
Ashford Hospitality Trust
AHT
$37.2M
| $941K | ﹤0.01% |
39,390
+7,210
| +22% | +$172K |
|
2355
Lindsay Corp
LNN
$1.53B
| $941K | ﹤0.01% |
8,000
-7,000
| -47% | -$823K |
|
2356
1-800-Flowers.com
FLWS
$339M
| $939K | ﹤0.01% |
134,085
-195,515
| -59% | -$1.37M |
|
2357
iShares Core Conservative Allocation ETF
AOK
$641M
| $937K | ﹤0.01% |
27,600
+4,300
| +18% | +$146K |
|
2358
Northrim BanCorp
NRIM
$488M
| $931K | ﹤0.01% |
23,500
-8,300
| -26% | -$329K |
|
2359
Comtech Telecommunications
CMTL
$71.7M
| $930K | ﹤0.01% |
106,250
+433
| +0.4% | +$3.79K |
|
2360
Adicet Bio
ACET
$67.6M
| $927K | ﹤0.01% |
677,000
+466,597
| +222% | +$639K |
|
2361
Mesa Laboratories
MLAB
$357M
| $925K | ﹤0.01% |
8,800
-14,200
| -62% | -$1.49M |
|
2362
Capital Group Growth ETF
CGGR
$16.2B
| $921K | ﹤0.01% |
37,600
+22,400
| +147% | +$549K |
|
2363
Sensus Healthcare
SRTS
$50.8M
| $920K | ﹤0.01% |
332,273
-35,661
| -10% | -$98.7K |
|
|
LOGC
2364
DELISTED
ContextLogic
LOGC
| $920K | ﹤0.01% |
208,577
-116,900
| -36% | -$516K |
|
2365
MGE Energy Inc
MGEE
$3.04B
| $918K | ﹤0.01% |
13,400
+1,100
| +9% | +$75.4K |
|
2366
Ring Energy
REI
$217M
| $918K | ﹤0.01% |
+470,600
| New | +$918K |
|
2367
Aware
AWRE
$59.9M
| $917K | ﹤0.01% |
664,850
-5,990
| -0.9% | -$8.26K |
|
2368
First Trust Dorsey Wright Focus 5 ETF
FV
$3.71B
| $917K | ﹤0.01% |
20,700
+16,200
| +360% | +$718K |
|
2369
Atossa Therapeutics
ATOS
$107M
| $915K | ﹤0.01% |
1,242,370
+168,300
| +16% | +$124K |
|
2370
Stepan Co
SCL
$1.1B
| $915K | ﹤0.01% |
12,200
-17,700
| -59% | -$1.33M |
|
2371
iShares MSCI World ETF
URTH
$5.82B
| $913K | ﹤0.01% |
7,599
-3,901
| -34% | -$469K |
|
2372
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.72B
| $912K | ﹤0.01% |
17,099
-13,501
| -44% | -$720K |
|
2373
First United
FUNC
$235M
| $912K | ﹤0.01% |
56,195
-5,420
| -9% | -$88K |
|
2374
GigaCloud Technology
GCT
$1.12B
| $912K | ﹤0.01% |
103,500
+67,200
| +185% | +$592K |
|
2375
Mineralys Therapeutics
MLYS
$2.89B
| $910K | ﹤0.01% |
+95,690
| New | +$910K |
|